Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1322/week)
    • Manufacturing(667/week)
    • Energy(528/week)
    • Technology(1303/week)
    • Other Manufacturing(451/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Design of experiments

Aug 11, 2020
JanOne Completes Stable Formulation of JAN101 in Preparation for Its First GMP Manufacturing Batch to Support Upcoming Clinical Trials
Jun 16, 2020
Signant Health Expands Its Pioneering Patient Engagement App, TrialGuide, to Enable Remote Participation in Global Clinical Trials
Jun 15, 2020
New Research Sheds Light on Intentional Non-adherence in Clinical Trials
Jun 10, 2020
Clinical Maestro adds LEAD Module to Modernize Accrual and Reforecasting Process for Clinical Trials
Jun 10, 2020
COTA Supports FDA Assessment of Real-World Data through Membership in COVID-19 Evidence Accelerator
Jun 09, 2020
MIVI Neuroscience Announces FDA IDE Clinical Study Approval For the MIVI Q Aspiration Catheter
Jun 08, 2020
Phase 2 Clinical Trial of LSD for "Suicide Headaches" Begins Treating Patients
Jun 02, 2020
Phlexglobal Providing Vital Support for COVID-19 Clinical Trials
Jun 01, 2020
Longeveron Announces Japanese Approval of Clinical Trial for Treatment of Aging Frailty With Longeveron's Stem Cells
Jun 01, 2020
RDIF and ChemRar to Deliver 60,000 Courses of the First COVID-19 Drug Registered in Russia, Avifavir, to the Country's Hospitals in June
May 26, 2020
Delve Health Announces the Addition of TeleVisit to Clinical StudyPal - Enabling Patient-Centric Clinical Trials
May 26, 2020
Arena Completes Full Enrollment of Etrasimod Phase 2 ADVISE Trial for Atopic Dermatitis, Provides Program Updates
May 19, 2020
Public mistrust of messaging during COVID-19 drives growth for AMCI Testing's Certified 3rd party evaluations
May 19, 2020
St. Elizabeth Healthcare Partners with CTI and Pulmotect Becoming First Hospital Site for Phase-2 Clinical Trial Targeting COVID-19
May 18, 2020
Global Clinical Trials for COVID-19: Summary of Antiviral and Vaccine Therapies in Pursuit of Regulatory Approval to Treat COVID-19
May 14, 2020
Q30 Innovations Requests FDA Authorization for Q-Collar Device Designed to Aid in the Protection of the Brain from the Effects of Head Impacts in Contact Sports
May 14, 2020
RegeneRx Joint Venture Announces Efficacy Results of Neurotrophic Keratopathy Phase 3 Clinical Trial with RGN-259
May 14, 2020
Milestone Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Corporate Update
May 07, 2020
Bioclinica Announces Comprehensive COVID-19 Clinical Endpoint Adjudication Solution
May 05, 2020
Synthetic Biologics Reports 2020 First Quarter Operational Highlights and Financial Results
  •  
  • Page 1
  • ››

Latest News

May 22, 2025

Pure Lithium and E3 Lithium Report Results From Phase 1 of the Lithium Metal Battery Joint Development...

May 22, 2025

Toyoda Gosei Launches Horizontal Recycling Technology for Plastic Automotive Parts

May 22, 2025

Brazilian Petrochemical Giant Opts for Penetron System to Secure Firefighting Tank

May 22, 2025

HAFNIA LIMITED: Ex Dividend USD 0.1015 on the Oslo Stock Exchange Today

May 22, 2025

Mitsubishi Electric’s ME Innovation Fund Invests in U.S. Startup Solestial

May 22, 2025

Sable Offshore Corp. Announces Upsize and Pricing of Public Offering of Common Stock

May 22, 2025

StandardAero Announces Pricing of Its Secondary Offering of 30,000,000 Shares of Common Stock by Affiliates...

May 22, 2025

Royal Gold Announces Third Quarter Dividend

View all News

Agenda

23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia